Cancer stem cells: the promise and the potential
Despite the advancement of treatment modalities, many cancer patients experience tumor recurrence and metastasis at regional or distant sites. Evolving understanding of tumor biology has led to the hypothesis that tumors may possess a stem cell-like subpopulation known as cancer stem cells (CSCs) th...
Uložené v:
| Vydané v: | Seminars in oncology Ročník 42 Suppl 1; s. S3 |
|---|---|
| Hlavní autori: | , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
01.04.2015
|
| Predmet: | |
| ISSN: | 1532-8708, 1532-8708 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Despite the advancement of treatment modalities, many cancer patients experience tumor recurrence and metastasis at regional or distant sites. Evolving understanding of tumor biology has led to the hypothesis that tumors may possess a stem cell-like subpopulation known as cancer stem cells (CSCs) that may be involved in driving tumor propagation and pathogenesis. Like normal stem cells (NSCs), CSCs can be identified by markers such as CD133, CD44, and ALDH. CSCs have the ability to self-renew and differentiate into different tumor components through stemness pathways, such as Wnt, TGF-β, STAT, and Hippo-YAP/TAZ, among others. In NSCs, stemness pathways are strictly regulated and control many important biologic processes, including embryogenesis and intestinal crypt cellular regulation. In contrast, stemness pathways in CSCs are significantly dysregulated. Combining current drugs with the targeting of these stemness pathways may significantly improve patient prognosis. The aim of this supplement is to update clinicians on the accumulated evidence characterizing the role of CSCs in tumor initiation, heterogeneity, therapy resistance, and recurrence and metastasis, and the potential for effectively treating patients. |
|---|---|
| AbstractList | Despite the advancement of treatment modalities, many cancer patients experience tumor recurrence and metastasis at regional or distant sites. Evolving understanding of tumor biology has led to the hypothesis that tumors may possess a stem cell-like subpopulation known as cancer stem cells (CSCs) that may be involved in driving tumor propagation and pathogenesis. Like normal stem cells (NSCs), CSCs can be identified by markers such as CD133, CD44, and ALDH. CSCs have the ability to self-renew and differentiate into different tumor components through stemness pathways, such as Wnt, TGF-β, STAT, and Hippo-YAP/TAZ, among others. In NSCs, stemness pathways are strictly regulated and control many important biologic processes, including embryogenesis and intestinal crypt cellular regulation. In contrast, stemness pathways in CSCs are significantly dysregulated. Combining current drugs with the targeting of these stemness pathways may significantly improve patient prognosis. The aim of this supplement is to update clinicians on the accumulated evidence characterizing the role of CSCs in tumor initiation, heterogeneity, therapy resistance, and recurrence and metastasis, and the potential for effectively treating patients.Despite the advancement of treatment modalities, many cancer patients experience tumor recurrence and metastasis at regional or distant sites. Evolving understanding of tumor biology has led to the hypothesis that tumors may possess a stem cell-like subpopulation known as cancer stem cells (CSCs) that may be involved in driving tumor propagation and pathogenesis. Like normal stem cells (NSCs), CSCs can be identified by markers such as CD133, CD44, and ALDH. CSCs have the ability to self-renew and differentiate into different tumor components through stemness pathways, such as Wnt, TGF-β, STAT, and Hippo-YAP/TAZ, among others. In NSCs, stemness pathways are strictly regulated and control many important biologic processes, including embryogenesis and intestinal crypt cellular regulation. In contrast, stemness pathways in CSCs are significantly dysregulated. Combining current drugs with the targeting of these stemness pathways may significantly improve patient prognosis. The aim of this supplement is to update clinicians on the accumulated evidence characterizing the role of CSCs in tumor initiation, heterogeneity, therapy resistance, and recurrence and metastasis, and the potential for effectively treating patients. Despite the advancement of treatment modalities, many cancer patients experience tumor recurrence and metastasis at regional or distant sites. Evolving understanding of tumor biology has led to the hypothesis that tumors may possess a stem cell-like subpopulation known as cancer stem cells (CSCs) that may be involved in driving tumor propagation and pathogenesis. Like normal stem cells (NSCs), CSCs can be identified by markers such as CD133, CD44, and ALDH. CSCs have the ability to self-renew and differentiate into different tumor components through stemness pathways, such as Wnt, TGF-β, STAT, and Hippo-YAP/TAZ, among others. In NSCs, stemness pathways are strictly regulated and control many important biologic processes, including embryogenesis and intestinal crypt cellular regulation. In contrast, stemness pathways in CSCs are significantly dysregulated. Combining current drugs with the targeting of these stemness pathways may significantly improve patient prognosis. The aim of this supplement is to update clinicians on the accumulated evidence characterizing the role of CSCs in tumor initiation, heterogeneity, therapy resistance, and recurrence and metastasis, and the potential for effectively treating patients. |
| Author | Ajani, Jaffer A Song, Shumei Hochster, Howard S Steinberg, Ira B |
| Author_xml | – sequence: 1 givenname: Jaffer A surname: Ajani fullname: Ajani, Jaffer A email: Jajani@mdanderson.org organization: Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine; Professor, Department of Epidemiology, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: Jajani@mdanderson.org – sequence: 2 givenname: Shumei surname: Song fullname: Song, Shumei organization: Associate Professor, Department of Gastrointestinal (GI) Medical Oncology-Research, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX – sequence: 3 givenname: Howard S surname: Hochster fullname: Hochster, Howard S organization: Associate Director, Yale Cancer Center; Professor of Medicine, Yale School of Medicine, New Haven, CT – sequence: 4 givenname: Ira B surname: Steinberg fullname: Steinberg, Ira B organization: Vice President, Medical Affairs, Boston Biomedical, Cambridge, MA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25839664$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNj0tLxEAQhAdZcR_6FyRHL4k9PZnMxJssrgoLHvQe5tHBLHmsmcnBf29kV_DU1UVRfLVmi37oibGEQ8ZBivtDFqhrZtMNbYbAZQY8A-AXbMWlwFQr0It_esnWIRwAkCvEK7ZEqUVZFPmKwdb0jsYkROoSR20bHpL4SclxHLomUGJ6f_qHSH1sTHvNLmvTBro53w173z19bF_S_dvz6_ZxnzopMaY1grGCW1N4XVh0JWiwqq4tgbZS-VIpWQosvctRC4LcSimk8NaR8hY37O7UOnN8TRRiNdP84pmehilUvNBCyXlZPkdvz9HJduSr49h0Zvyu_jbiD5T2V6w |
| CitedBy_id | crossref_primary_10_1038_nrdp_2017_36 crossref_primary_10_3390_cancers11070992 crossref_primary_10_1016_j_tiv_2021_105155 crossref_primary_10_1177_1010428317701654 crossref_primary_10_3390_molecules26082278 crossref_primary_10_1016_j_currproblcancer_2018_01_003 crossref_primary_10_3390_cells9010008 crossref_primary_10_4137_GEG_S35500 crossref_primary_10_1016_j_cellsig_2016_08_004 crossref_primary_10_1016_j_canlet_2019_01_043 crossref_primary_10_3389_fendo_2021_755805 crossref_primary_10_1186_s12935_018_0654_4 crossref_primary_10_1016_j_critrevonc_2017_02_025 crossref_primary_10_1007_s12035_015_9187_1 crossref_primary_10_3390_cells11213492 crossref_primary_10_15252_embr_201949689 crossref_primary_10_1016_j_jff_2016_06_007 crossref_primary_10_1177_15347354221123019 crossref_primary_10_3389_fchem_2021_686303 crossref_primary_10_3389_fcell_2024_1446452 crossref_primary_10_1002_pros_23779 crossref_primary_10_1016_j_addr_2018_04_005 crossref_primary_10_1016_j_gene_2025_149432 crossref_primary_10_1111_jcmm_13959 crossref_primary_10_1302_2046_3758_105_BJR_2020_0262_R3 crossref_primary_10_1016_j_canlet_2021_02_002 crossref_primary_10_1007_s12013_024_01385_8 crossref_primary_10_3390_cells8080926 crossref_primary_10_1155_2022_4107433 crossref_primary_10_1007_s10555_024_10168_9 crossref_primary_10_1007_s11033_019_05058_1 crossref_primary_10_1007_s13277_015_4155_y crossref_primary_10_3389_fcell_2019_00016 crossref_primary_10_1038_s41598_017_10675_6 crossref_primary_10_1016_j_ejps_2023_106586 crossref_primary_10_3390_cells8080812 crossref_primary_10_1016_j_bbrc_2015_11_134 crossref_primary_10_3389_fphar_2017_00035 crossref_primary_10_3892_ol_2018_9796 crossref_primary_10_1007_s13277_016_5351_0 crossref_primary_10_1016_j_yexmp_2017_11_009 crossref_primary_10_1016_j_bbrc_2020_07_040 crossref_primary_10_1016_j_taap_2018_03_024 crossref_primary_10_1155_2019_3516973 crossref_primary_10_1016_j_lfs_2021_119150 crossref_primary_10_1186_s12906_023_04016_6 crossref_primary_10_2147_BCTT_S489246 crossref_primary_10_1038_s41698_023_00436_2 crossref_primary_10_1186_s40659_024_00551_9 crossref_primary_10_3390_cells8121658 crossref_primary_10_1093_carcin_bgw092 crossref_primary_10_1371_journal_pone_0149897 crossref_primary_10_3390_cancers15051608 crossref_primary_10_3390_ijms231810663 crossref_primary_10_3389_fonc_2021_772134 crossref_primary_10_1016_j_bcp_2020_114205 crossref_primary_10_1016_j_phymed_2018_04_016 crossref_primary_10_1002_med_21886 crossref_primary_10_1016_j_ctrv_2015_11_011 crossref_primary_10_3390_jcm9010087 crossref_primary_10_1002_cam4_4377 crossref_primary_10_1016_j_ebiom_2019_10_020 crossref_primary_10_1080_14737159_2016_1187563 crossref_primary_10_3389_fcell_2024_1397788 crossref_primary_10_3389_fonc_2018_00475 crossref_primary_10_3390_cells9061401 crossref_primary_10_1371_journal_pone_0202588 crossref_primary_10_1007_s10555_019_09793_6 crossref_primary_10_1002_jcp_28824 crossref_primary_10_1186_s13287_022_02856_6 crossref_primary_10_1007_s11523_017_0508_3 crossref_primary_10_1016_j_envres_2023_117443 crossref_primary_10_1186_s12943_019_1064_5 crossref_primary_10_1097_BTO_0000000000000408 crossref_primary_10_1016_j_semcancer_2020_03_016 crossref_primary_10_1038_cddiscovery_2016_36 crossref_primary_10_3390_ijms25105569 crossref_primary_10_3390_cancers13143548 crossref_primary_10_3389_fimmu_2023_1214425 crossref_primary_10_3390_ijms17071163 crossref_primary_10_1002_cncr_30538 crossref_primary_10_1007_s12015_022_10426_9 crossref_primary_10_1016_j_prp_2020_153226 crossref_primary_10_1158_1078_0432_CCR_18_1029 crossref_primary_10_1080_07391102_2023_2218936 crossref_primary_10_1186_s12943_017_0602_2 crossref_primary_10_1111_jfbc_13868 crossref_primary_10_1111_bjh_15711 crossref_primary_10_3390_cells12030506 crossref_primary_10_3390_ijms23095120 crossref_primary_10_2217_bmm_2020_0069 crossref_primary_10_3390_toxins8050127 crossref_primary_10_1016_j_hermed_2020_100339 crossref_primary_10_1002_anbr_202100017 crossref_primary_10_1016_j_mvr_2015_12_001 crossref_primary_10_3892_ijo_2020_5008 crossref_primary_10_1093_nar_gkz128 crossref_primary_10_1016_j_matbio_2016_01_006 crossref_primary_10_3390_molecules25143128 crossref_primary_10_1016_j_canlet_2024_217354 crossref_primary_10_3390_cancers13102491 crossref_primary_10_1002_mog2_62 crossref_primary_10_3892_ol_2019_10535 crossref_primary_10_3390_cells13020125 crossref_primary_10_1016_j_pharmthera_2021_107800 crossref_primary_10_1136_gutjnl_2020_321175 crossref_primary_10_1016_j_prp_2020_152919 crossref_primary_10_3390_ijms22031424 crossref_primary_10_1016_j_phrs_2016_12_005 crossref_primary_10_1016_j_bbamcr_2015_07_008 crossref_primary_10_1186_s12964_020_00627_5 crossref_primary_10_1016_j_biochi_2015_12_001 crossref_primary_10_1007_s40778_017_0092_6 crossref_primary_10_1016_j_omto_2019_08_004 crossref_primary_10_1158_1078_0432_CCR_22_2791 crossref_primary_10_3390_ijms24119450 crossref_primary_10_1186_s13046_018_0832_1 crossref_primary_10_1080_10408398_2016_1231168 crossref_primary_10_1186_s12906_016_1254_2 crossref_primary_10_1038_s41389_018_0029_7 crossref_primary_10_1002_jcp_29437 crossref_primary_10_2147_IJGM_S352574 crossref_primary_10_2147_OTT_S249353 crossref_primary_10_1002_mco2_176 crossref_primary_10_2174_1574888X13666180810120012 crossref_primary_10_1097_MD_0000000000004764 crossref_primary_10_1097_MD_0000000000004765 crossref_primary_10_1016_j_jep_2017_06_004 crossref_primary_10_1016_j_surg_2024_07_056 crossref_primary_10_1002_cam4_6520 crossref_primary_10_1186_s12885_015_2025_z crossref_primary_10_3389_fonc_2020_573318 crossref_primary_10_3390_cells13010096 crossref_primary_10_3389_fcell_2021_795874 crossref_primary_10_1186_s13630_016_0035_3 crossref_primary_10_1038_s41419_018_0361_z crossref_primary_10_1002_ddr_70020 crossref_primary_10_3892_ol_2018_9824 crossref_primary_10_1016_j_canlet_2025_217695 crossref_primary_10_3390_bioengineering6030073 crossref_primary_10_3390_cancers14153786 crossref_primary_10_1007_s00148_018_0706_z crossref_primary_10_1097_MD_0000000000004766 crossref_primary_10_3390_ph14010060 crossref_primary_10_1038_s41416_020_0792_z crossref_primary_10_1016_j_addr_2015_10_013 crossref_primary_10_1002_ijc_32312 crossref_primary_10_1016_j_tranon_2021_101134 crossref_primary_10_1155_2020_8810476 crossref_primary_10_3389_fphar_2021_709324 crossref_primary_10_1016_j_bbamcr_2015_08_003 crossref_primary_10_1002_cncr_30953 crossref_primary_10_1038_s41419_021_04005_y crossref_primary_10_1186_s12859_023_05384_z crossref_primary_10_1038_s41420_018_0124_8 crossref_primary_10_1177_1534735418786027 crossref_primary_10_1016_j_bbcan_2020_188414 crossref_primary_10_1186_s13046_019_1129_8 crossref_primary_10_1007_s10014_025_00505_3 crossref_primary_10_1002_ijc_32564 crossref_primary_10_1016_j_tranon_2023_101803 crossref_primary_10_1158_1535_7163_MCT_17_0560 crossref_primary_10_3389_fonc_2019_01359 crossref_primary_10_1016_j_semcancer_2022_10_003 crossref_primary_10_1016_j_lungcan_2018_12_001 crossref_primary_10_3892_or_2022_8396 crossref_primary_10_1002_jcb_29525 crossref_primary_10_1007_s13402_021_00636_7 crossref_primary_10_1080_08830185_2019_1669593 crossref_primary_10_1186_s12967_018_1495_6 crossref_primary_10_3923_ijp_2019_523_532 crossref_primary_10_1007_s00432_016_2157_9 crossref_primary_10_1007_s00432_023_05589_y crossref_primary_10_1038_srep25261 crossref_primary_10_1186_s13287_020_02018_6 crossref_primary_10_1016_j_ebiom_2019_03_076 crossref_primary_10_52711_2231_5691_2023_00049 crossref_primary_10_3390_cancers9110158 crossref_primary_10_1186_s13578_020_00449_5 crossref_primary_10_1080_10667857_2021_1924436 crossref_primary_10_2147_CMAR_S252292 crossref_primary_10_1007_s13258_017_0639_z crossref_primary_10_1007_s40675_017_0062_7 crossref_primary_10_1177_15347354231223499 crossref_primary_10_1007_s11030_025_11179_6 crossref_primary_10_1038_bjc_2017_225 crossref_primary_10_1073_pnas_1905973116 crossref_primary_10_1007_s13346_020_00863_9 crossref_primary_10_3892_etm_2016_3983 crossref_primary_10_3390_cancers11050732 crossref_primary_10_1186_s12967_022_03768_y crossref_primary_10_1016_j_ejphar_2024_176387 crossref_primary_10_1016_j_ejphar_2020_173840 crossref_primary_10_1016_j_critrevonc_2020_103095 crossref_primary_10_3390_ijms22094682 crossref_primary_10_1016_j_breast_2017_11_009 crossref_primary_10_1016_j_tibs_2016_01_003 crossref_primary_10_3390_ijms22073756 crossref_primary_10_1038_s41392_020_0110_5 crossref_primary_10_3390_ijms23169341 crossref_primary_10_1089_ten_teb_2015_0567 crossref_primary_10_4252_wjsc_v10_i12_183 crossref_primary_10_3390_cells9081896 crossref_primary_10_3390_life12020184 |
| ContentType | Journal Article |
| Copyright | Copyright © 2015 Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: Copyright © 2015 Elsevier Inc. All rights reserved. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1053/j.seminoncol.2015.01.001 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1532-8708 |
| ExternalDocumentID | 25839664 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GroupedDBID | --- --K .1- .55 .FO .GJ 0R~ 123 1P~ 3O- 4.4 457 4CK 53G 5RE AAEDW AALRI AAQOH AAQQT AAQXK AAWTL AAXUO ABFRF ABJNI ABOCM ABUDA ABWVN ACGFO ACRPL ADBBV ADMUD ADNMO AEFWE AENEX AEVXI AFCTW AFETI AFFNX AFJKZ AFRHN AFTJW AGHFR AGRDE AITUG AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ ASPBG AVWKF AZFZN CGR CS3 CUY CVF DU5 EBS ECM EIF EJD F5P FDB FEDTE FGOYB GBLVA HVGLF HZ~ IH2 J5H K-O L7B MJL N4W NPM O9- OC~ OO- P2P R2- RIG ROL SEL SES SJN TWZ UDS X7M Z5R ZGI ZXP 7X8 AIGII |
| ID | FETCH-LOGICAL-c552t-f20ab31ba6d86b2c9080b7ffbe08b57d97759329dc4283e04b55353dbce7db2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 246 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000352757800002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1532-8708 |
| IngestDate | Fri Sep 05 06:50:48 EDT 2025 Thu Jan 02 22:21:26 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| License | Copyright © 2015 Elsevier Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c552t-f20ab31ba6d86b2c9080b7ffbe08b57d97759329dc4283e04b55353dbce7db2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 25839664 |
| PQID | 1683757084 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1683757084 pubmed_primary_25839664 |
| PublicationCentury | 2000 |
| PublicationDate | 2015-04-01 |
| PublicationDateYYYYMMDD | 2015-04-01 |
| PublicationDate_xml | – month: 04 year: 2015 text: 2015-04-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Seminars in oncology |
| PublicationTitleAlternate | Semin Oncol |
| PublicationYear | 2015 |
| SSID | ssj0021722 |
| Score | 2.5667877 |
| SecondaryResourceType | review_article |
| Snippet | Despite the advancement of treatment modalities, many cancer patients experience tumor recurrence and metastasis at regional or distant sites. Evolving... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | S3 |
| SubjectTerms | Biomarkers, Tumor - metabolism Breast Neoplasms - metabolism Breast Neoplasms - pathology Drug Resistance, Neoplasm Female Gastrointestinal Neoplasms - metabolism Gastrointestinal Neoplasms - physiopathology Hematologic Neoplasms - metabolism Hematologic Neoplasms - pathology Humans Hyaluronan Receptors - metabolism Molecular Targeted Therapy - methods Neoplasm Recurrence, Local Neoplasms - metabolism Neoplasms - pathology Neoplasms - therapy Neoplastic Stem Cells - drug effects Neoplastic Stem Cells - metabolism Neoplastic Stem Cells - pathology Neoplastic Stem Cells - radiation effects Prognosis Signal Transduction Transforming Growth Factor beta - metabolism Tumor Microenvironment Wnt Signaling Pathway |
| Title | Cancer stem cells: the promise and the potential |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/25839664 https://www.proquest.com/docview/1683757084 |
| Volume | 42 Suppl 1 |
| WOSCitedRecordID | wos000352757800002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7Uinjx_agvInhdutlks1kvIsXipaWgh97CPkHQtjbV3-9MstWTIHhJyCFk-GZ299udyTeE3KDoWil0oMZpRfPSZVQx5qgyAlY3bjOdh6bZhByNyslEjeOBWx3LKldzYjNRu5nFM_JeWsBWSkhW5nfzd4pdozC7GltorJNOBlQGo1pOvrMI2HuJt3qpOOpZGSt5IO56-Ef32wvssAFuLPBqxTtZ-jvRbBacwe5_Td0jO5FqJvdtbOyTNT89IFvDmEw_JKyPHl8kKOWc4AF-fZsAHUzga-B8n-ipa59nSywp0q9H5Gnw8Nx_pLGBArWA85IGzrTJUqMLVxaGWwX00MgQjGelEdIB9xPA35SzKLvmWW4EeChzxnrpDD8mGwCQPyUJ51Yro-Amfa5CapjQFqX4uRVByaxLrldIVGAhmqynfvZRVz9YdMlJC2c1b3U0Ki6AnRVFfvaHt8_JNnqprZm5IJ0Ag9Nfkk37uXypF1eN3-E6Gg-_ACiYtnQ |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cancer+stem+cells%3A+the+promise+and+the+potential&rft.jtitle=Seminars+in+oncology&rft.au=Ajani%2C+Jaffer+A&rft.au=Song%2C+Shumei&rft.au=Hochster%2C+Howard+S&rft.au=Steinberg%2C+Ira+B&rft.date=2015-04-01&rft.eissn=1532-8708&rft.volume=42+Suppl+1&rft.spage=S3&rft_id=info:doi/10.1053%2Fj.seminoncol.2015.01.001&rft_id=info%3Apmid%2F25839664&rft_id=info%3Apmid%2F25839664&rft.externalDocID=25839664 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1532-8708&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1532-8708&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1532-8708&client=summon |